Rhenman & Partners Asset Management AB grew its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 27.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 121,189 shares of the company's stock after purchasing an additional 26,000 shares during the period. Rhenman & Partners Asset Management AB owned about 0.10% of Privia Health Group worth $2,369,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Riverbridge Partners LLC increased its holdings in Privia Health Group by 19.7% in the 4th quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company's stock worth $113,868,000 after purchasing an additional 958,418 shares in the last quarter. Loomis Sayles & Co. L P grew its stake in Privia Health Group by 55.0% during the fourth quarter. Loomis Sayles & Co. L P now owns 1,418,234 shares of the company's stock worth $27,727,000 after purchasing an additional 503,002 shares during the period. JPMorgan Chase & Co. lifted its stake in Privia Health Group by 111.7% in the fourth quarter. JPMorgan Chase & Co. now owns 398,738 shares of the company's stock valued at $7,795,000 after buying an additional 210,354 shares during the period. Barclays PLC increased its stake in shares of Privia Health Group by 240.3% in the 3rd quarter. Barclays PLC now owns 224,018 shares of the company's stock valued at $4,079,000 after acquiring an additional 158,188 shares in the last quarter. Finally, Soros Fund Management LLC lifted its position in shares of Privia Health Group by 25.0% during the 3rd quarter. Soros Fund Management LLC now owns 750,000 shares of the company's stock valued at $13,658,000 after acquiring an additional 150,000 shares during the period. Institutional investors own 94.48% of the company's stock.
Privia Health Group Stock Performance
Shares of Privia Health Group stock traded up $0.29 during trading on Thursday, hitting $23.34. The company's stock had a trading volume of 381,153 shares, compared to its average volume of 784,415. Privia Health Group, Inc. has a 52 week low of $15.92 and a 52 week high of $26.04. The company has a fifty day simple moving average of $23.73 and a two-hundred day simple moving average of $21.41. The company has a market capitalization of $2.83 billion, a PE ratio of 233.12, a P/E/G ratio of 3.47 and a beta of 0.88.
Analyst Ratings Changes
A number of equities research analysts have commented on PRVA shares. Piper Sandler raised their price objective on Privia Health Group from $25.00 to $40.00 and gave the company an "overweight" rating in a research note on Friday, February 28th. Truist Financial boosted their target price on shares of Privia Health Group from $27.00 to $28.00 and gave the stock a "buy" rating in a research report on Thursday. Canaccord Genuity Group increased their price objective on Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a research note on Friday, February 28th. Stephens reiterated an "overweight" rating and set a $26.00 price target on shares of Privia Health Group in a report on Thursday, January 2nd. Finally, JMP Securities set a $29.00 target price on shares of Privia Health Group in a report on Friday, February 28th. One investment analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus price target of $26.87.
Get Our Latest Stock Report on PRVA
Insider Transactions at Privia Health Group
In related news, CFO David Mountcastle sold 5,630 shares of the firm's stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total value of $125,999.40. Following the sale, the chief financial officer now owns 179,676 shares in the company, valued at approximately $4,021,148.88. This trade represents a 3.04 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 14.20% of the company's stock.
Privia Health Group Profile
(
Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Further Reading
Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
